UPMC Hillman Cancer Center Italy

UPMC Hillman Cancer Center Italy, established in 2016 in Rome, is the European extension of the renowned UPMC Hillman Cancer Center based in Pittsburgh, Pennsylvania. With 50 beds dedicated exclusively to oncology, the center brings world-class American cancer treatment protocols and research capabilities to the heart of Italy. The center holds JCI accreditation, ensuring that all clinical processes meet the highest international standards for patient safety and quality of care. Its cancer treatment programs encompass the full spectrum of oncological care, from early diagnosis and screening to advanced therapeutic interventions and survivorship programs. Radiation therapy at UPMC Hillman Italy utilizes the latest linear accelerator technology for precise tumor targeting with minimal damage to surrounding healthy tissue. The surgical oncology department performs complex tumor resections using minimally invasive and robotic-assisted techniques, enabling faster patient recovery and improved outcomes. The hematology department specializes in blood cancers including leukemia, lymphoma, and multiple myeloma, offering both standard and investigational treatment protocols. The immunotherapy program provides access to cutting-edge cancer immunotherapy treatments, including checkpoint inhibitors and targeted therapy regimens developed through UPMC's extensive research network. International patients benefit from UPMC's global reputation, seamless care coordination between its American and Italian facilities, and Rome's accessibility as a major European hub. The center's integration with UPMC's research infrastructure means patients may have access to clinical trials and novel therapies not widely available elsewhere in Europe.